Clostridium difficile--more difficult than ever.

By C. Kelly, J. Lamont. New England Journal of Medicine, 2008

1,380 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea (2009, background): “Unfortunately, the same problem is encountered by others treating this disease.(1) In the studies reported here, we used a molecular approach to gain a better understanding of the bacterial composition of the GI tract in a CDAD patient.”
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial (2019, neutral): “007 Clinical remission 18/38 (47) 6/35 (17) 30 (7 to 51) 4.”
Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota (2017, background): “39 40 Phyllobacterium , which are environmental bacteria commonly found in plant roots, were too identified at higher abundance in gastric carcinoma.”
Fecal microbiota transplantation and emerging applications (2012, background): “The risk of CDI relapse after initial treatment is approximately 20–25%”
The Epidemiology of Community-acquired Clostridium difficile infection: A population-based study (2011, background): “1 ) and the principal cause of infectious diarrhea in hospitalized patients (”
Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. (2014, neutral): “3) [11-89] 3 (3-5) [2-6] 10 (8-15) [6-30] 5 (5-7) [2-9] 4.”